Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Berg

Showing results (441-450 of 493) with videos related to

Pageof 50
Sort By:
Journal of Neuroscience Research|November 10, 2022
Motor cortical excitability and pre-supplementary motor area neurochemistry in healthy adults with substantia nigra hyperechogenicityGabrielle Todd, Caroline D Rae, Janet L Taylor, et al.
Annals of Clinical and Translational Neurology|October 24, 2024
Insular monoaminergic deficits in prodromal α-synucleinopathiesAndrea Pilotto, Alice Galli, Cinzia Zatti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 13, 2016
Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE studyElke Kalbe, Sarah Petra Rehberg, Ines Heber, et al.
Journal of Neuroinflammation|May 26, 2016
Inflammatory profile in LRRK2-associated prodromal and clinical PDKathrin Brockmann, Anja Apel, Claudia Schulte, et al.
Frontiers in Aging Neuroscience|July 23, 2016
Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons LearnedSebastian Heinzel, Benjamin Roeben, Yoav Ben-Shlomo, et al.
Archives of Neurology|July 13, 2011
Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older personsDaniela Berg, Klaus Seppi, Stefanie Behnke, et al.
Journal of Parkinson'S Disease|July 31, 2025
Progression to Parkinson's dementia is not modulated by genetic risk variants for Alzheimer's or Parkinson's diseaseKayenat Parveen, J Alexander Ross, Hendrik van der Wurp, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 15, 2020
Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease PenetranceMarta San Luciano, Caroline M Tanner, Cheryl Meng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2020
Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's DiseaseFranziska Hopfner, Stefanie H Mueller, Silke Szymczak, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2015
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficitsNorbert Schuff, I-Wei Wu, Shannon Buckley, et al.
Pageof 50

Showing results (441-450 of 493) with videos related to

Sort By:
Pageof 50
Journal of Neuroscience Research|November 10, 2022
Motor cortical excitability and pre-supplementary motor area neurochemistry in healthy adults with substantia nigra hyperechogenicityGabrielle Todd, Caroline D Rae, Janet L Taylor, et al.
Annals of Clinical and Translational Neurology|October 24, 2024
Insular monoaminergic deficits in prodromal α-synucleinopathiesAndrea Pilotto, Alice Galli, Cinzia Zatti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 13, 2016
Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE studyElke Kalbe, Sarah Petra Rehberg, Ines Heber, et al.
Journal of Neuroinflammation|May 26, 2016
Inflammatory profile in LRRK2-associated prodromal and clinical PDKathrin Brockmann, Anja Apel, Claudia Schulte, et al.
Frontiers in Aging Neuroscience|July 23, 2016
Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons LearnedSebastian Heinzel, Benjamin Roeben, Yoav Ben-Shlomo, et al.
Archives of Neurology|July 13, 2011
Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older personsDaniela Berg, Klaus Seppi, Stefanie Behnke, et al.
Journal of Parkinson'S Disease|July 31, 2025
Progression to Parkinson's dementia is not modulated by genetic risk variants for Alzheimer's or Parkinson's diseaseKayenat Parveen, J Alexander Ross, Hendrik van der Wurp, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 15, 2020
Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease PenetranceMarta San Luciano, Caroline M Tanner, Cheryl Meng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2020
Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's DiseaseFranziska Hopfner, Stefanie H Mueller, Silke Szymczak, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2015
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficitsNorbert Schuff, I-Wei Wu, Shannon Buckley, et al.
Pageof 50